Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside Properties reiterates guidance as completions rise
11 Oct 2018 - UK Earnings, Trading Statements Calendar - Next 7 Days
4 Oct 2018 - Countryside Properties Appoints Scott As CFO, Worthington Becomes COO
1 Oct 2018 - Countryside CFO steps up to COO role
1 Oct 2018 - Wednesday broker round-up
12 Sep 2018 - Berenberg selects its top-picks in UK construction
24 Aug 2018 - DIRECTOR DEALINGS SUMMARY: Countryside CEO Sells 1.8 Million Shares
15 Aug 2018 - DIRECTOR DEALINGS: Countryside CEO Sells Shares Worth GBP6 Million
15 Aug 2018
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties reiterates guidance as completions rise
(Sharecast News) - Countryside Properties reiterated its medium-term guidance on Thursday as it posted a jump in total completions and said demand for...
UK Earnings, Trading Statements Calendar - Next 7 Days
Friday 5 October Motorpoint GroupTrading Statement Monday 8 GroupTrading of
Countryside Properties Appoints Scott As CFO, Worthington Becomes COO
LONDON (Alliance News) - Countryside Properties PLC on Monday said it appointed Chief Financial Officer Becky Worthington as chief operating officer w...
Countryside CFO steps up to COO role
(Sharecast News) - Countryside Properties said chief financial officer Becky Worthington would become chief operating officer with immediate effect.
Wednesday broker round-up
(Sharecast News) - Goals Soccer Centres: Peel Hunt upgrades to buy with a target price of 100p.
Berenberg selects its top-picks in UK construction
(Sharecast News) - Analysts at Berenberg sounded a positive note on several of the UK's main housebuilders, arguing that investors' concerns were over...
DIRECTOR DEALINGS SUMMARY: Countryside CEO Sells 1.8 Million Shares
LONDON (Alliance News) - The following is a summary of director dealings reported in London on Wednesday.----------Countryside Properties said that Ch...
DIRECTOR DEALINGS: Countryside CEO Sells Shares Worth GBP6 Million
LONDON (Alliance News) - Countryside Properties PLC said Wednesday that Chief Executive Officer Ian Sutcliffe sold 1.8 million shares in the company.S...
Follow the stocks
